Researchers developed a blue light-driven technique that modifies drug molecules in fewer steps, a method that could ...

Accelerating Drug Discovery with AI and Next-Generation Automation The pharmaceutical industry is currently witnessi ...

Pelago Bioscience, a specialist drug discovery focused contract research organization (CRO), known for its industry-leading ...

South Korean researchers have developed an automated, modular cell-free protein synthesis platform that slashes preparation ...

The novel kit leverages advanced cell-free protein synthesis technology to enable rapid, efficient in vitro production of target proteins and antibodies–eliminating the constraints of traditional cell ...

Researchers at the Purdue Institute for Cancer Research (PICR) have developed a next-generation technology platform designed to accelerate one of the slowest and most challenging stages of cancer drug ...

Structural complexity in modern small molecules is reshaping what drug development partners must deliver from discovery through commercial supply.Targeted protein degraders, covalent agents, and a new ...

Diversity-Oriented Synthesis (DOS) has emerged as a cornerstone of modern drug discovery by furnishing large, structurally rich collections of small molecules that explore uncharted regions of ...

Spirocyclic architectures have emerged as privileged scaffolds in contemporary medicinal chemistry, offering unique three-dimensional shapes that enhance target engagement, improve pharmacokinetic ...

AI-driven small molecule discovery, which underlies most drugs on the market, is a challenge being tackled through science and technology ...

This Brush Up is sponsored by MilliporeSigma. Learn more about therapeutic synthesis pathways. Drug development is a process that spans many years, from the initial phase of identifying potential drug ...